International Expert Consensus on Defining Textbook Oncologic Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis

Author:

Zohar Nitzan12,Nevler Avinoam1,Esquivel Jesús3,Yeo Charles J1,Benvenisti Haggai2,Elbaz Nadav2,Assaf Dan2,Mor Eyal2,Bowne Wilbur B1,

Affiliation:

1. Jefferson Pancreas, Biliary and Related Cancer Center, Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA

2. Department of General and Oncological Surgery - Surgery C, Sheba Medical Center, Tel-Hashomer, Israel.

3. Beebe Healthcare, Lewes, DE, USA

Abstract

Background: Textbook oncologic outcome (TOO) is a composite metric shown to correlate with improved survival following curative intent oncologic procedures. Despite increasing use among disciplines in surgical oncology, no consensus exists for its definition in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: An international consensus-based study employed a Delphi methodology to achieve agreement. Fifty-four senior surgeons from the peritoneal surface malignancies field received a questionnaire comprised of TOO parameters divided into 3 surgical domains: operative, short-term and long-term postoperative outcomes. Two online meetings with participants defined the new criteria. Consensus was achieved when 75% agreement rate was reached. Clinical data of patients who underwent CRS/HIPEC for colorectal peritoneal metastasis (CPM) between 2010–2022 from one designated center (SMC) were collected, the consensus definition applied and outcomes analyzed. Results: Thirty-eight surgeons (70%) participated. Expert consensus TOO parameters for CPM-CRS/HIPEC included the absence of: unplanned re-operations during 30-days post-operation, severe postoperative complications (Clavien-Dindo≥III), unplanned readmissions during 30 days post-operation, 90-day postoperative mortality, and contraindications for chemotherapy within 12 weeks from operation, and included the achievement of complete cytoreduction (CC-0). The study cohort consisted of 251 patients; 151 patients (60%) met TOO criteria. Patients who achieved TOO had significantly better overall survival (median 67.5 months, CI 95%) vs patients who did not achieve TOO (median 44.6 months, CI 95%, p-value<0.001) and significantly improved disease-free survival (median, 12 months, CI 95%, vs. 9 months, CI 95%, p-value=0.01). Conclusion: Achievement of TOO as defined by consensus statement is associated with improved survival.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3